The market punished the telco after it posted a 78% collapse in net profit for the first six months and downgraded its guidance.
It will manufacture the product itself with imported ingredients.
Covid-19 lockdowns took their toll on the NZX/ASX-listed company.
Omicron headwind and border reopening tailwind creates turbulence.
It is the first major New Zealand retailer to make the move.
CEO designate Dr Sinan Altug has been with the company 20 years.
Broadcaster will lease back its main production facility for at least five years.
Alt Ventures’ new fund is focused on up-and-coming Kiwi gaming studios.
Punakaiki Fund and Amplo contribute to Series B round.
The medical cannabis company listed on the NZX in October.